In line with our earlier observations of EGFR mutations (e.g., T790M/L858R) in CTCs and matched tumor tissue,12 this study provides the molecular evidence linking a sold tumor with single-CTC-based indicator associated with clinical presentation at the transcript level, highlighting promising predictive value of circulating biomarkers. Here, EGFR is linked to neoplasm.